Veraxa Biotech AGの企業情報（従業員数・代表者名など）
最終更新日：2026年8月7日
特色
Veraxa Biotech AG is a Switzerland-based Company that develops antibody-based therapeutics for the treatment of cancer. The Company focuses on advancing proprietary platform technologies designed to generate targeted oncology therapies with improved safety and efficacy profiles. Its approach originates from scientific discoveries at the European Molecular Biology Laboratory, supporting the development of next-generation antibody-based drug candidates. The Company aims to expand treatment options for solid tumors by enabling more precise targeting mechanisms and potentially broader therapeutic windows compared with conventional therapies, addressing unmet needs across oncology markets through platform-driven innovation.
企業情報
| 英文社名 | Veraxa Biotech AG |
|---|---|
| 本社所在地 | Talacker 35 ZUERICH, 8001 CHE |
| 電話番号 | 44 385-8450 |
| 設立年月 | 2025年6月 |
| 代表者名 | --- |
| 業種名 | 医療関連（Health Care） |
| 市場名 | NASDAQ National Market System |
| 従業員数 | --- |
| ウェブサイト | --- |
企業の強みが業績にどのように表れているか、業績情報よりご確認いただけます。
業績情報を見る